EDN1 and coronary artery disorder: More specifically, vascular endothelial dysfunction could lead to imbalances in vasoactive substance release, namely lowered nitric oxide (NO), along with increased endothelin-1 (ET-1) and angiotensin II (Ang II), leading to aggravated vasoconstriction, thrombosis, and CAD progression.